$1.35M Atty Fee Proposed For Calif., Del. Drug Trial Suits
Seven law firms will split a stipulated $1.35 million fee if a Delaware court approves a shareholder derivative settlement agreement with pharmaceutical company Geron Corp. and its leaders over alleged "false...To view the full article, register now.
Already a subscriber? Click here to view full article